Hypertension Diagnostics, Inc.
HDII · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $3,792 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $2,838 |
| Gross Profit | $0 | $0 | $0 | $954 |
| % Margin | – | – | – | 25.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $122 | $11 | $420 | $918 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $8 |
| Operating Expenses | $122 | $11 | $420 | $1,115 |
| Operating Income | -$122 | -$11 | -$420 | -$161 |
| % Margin | – | – | – | -4.2% |
| Other Income/Exp. Net | $29 | $0 | $3,714 | $36 |
| Pre-Tax Income | -$93 | -$11 | $3,294 | -$125 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$93 | -$11 | $3,294 | -$125 |
| % Margin | – | – | – | -3.3% |
| EPS | -0 | -0 | 0.024 | -0.001 |
| % Growth | -300% | -100.4% | 2,777.8% | – |
| EPS Diluted | -0 | -0 | 0.024 | -0.001 |
| Weighted Avg Shares Out | 213,088 | 149,182 | 136,814 | 136,814 |
| Weighted Avg Shares Out Dil | 213,088 | 149,182 | 136,814 | 136,814 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $27 |
| Interest Expense | $0 | $0 | $0 | $162 |
| Depreciation & Amortization | $228 | $237 | $206 | $36 |
| EBITDA | $135 | $226 | $3,500 | $72 |
| % Margin | – | – | – | 1.9% |